Celularity Inc (CELU) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Celularity Inc   (NASDAQ: CELU)
 

Celularity Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Celularity Inc inventory turnover ratio, the Celularity Inc 's ability to sell and replace its inventory in the fourth quarter 2025, sequentially increased to 5.84 in the fourth quarter 2025, a new company high. Average inventory processing period, for the Celularity Inc in Dec 31 2025 quarter, has decreased to 63 days, compare to 84 days, in the Sep 30 2025 quarter.

Within Healthcare sector 73 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2025, to 598, from total ranking in the third quarter 2025 at 834.

CELU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Celularity Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELU Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Inventory Growth -89.44 % -35.33 % 51.29 % 67.44 % -5.98 %
Y / Y Cost of Sales Growth 0.42 % 0.54 % 146.91 % 116.71 % -23.58 %
Inventory Turnover Ratio (TTM) 5.84 4.32 4.01 3.66 3.75
CELU's Total Ranking # 598 # 834 # 843 # 1053 # 1053
Average inventory processing period 62 85 91 100 97
Seq. Inventory Growth -77.72 % -41.88 % -28.84 % 14.57 % 36.49 %
Seq. Cost of Sales Growth 88.88 % -25.52 % 47.5 % -51.6 % 89.11 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 74
Overall Market # 598

Inventory Turnover Ratio Statistics
High Average Low
5.84 2.7 0.19
(Dec 31 2025)   (Dec 31 2022)



CELU Company Profile >> Back to CELU Efficiency Comparisons >> Compare CELU Inventory Turnover Ratio to its Competitors

Financial Statements
Celularity Inc 's Inventories $ 1 Millions Visit CELU's Balance sheet
Celularity Inc 's Cost of Revenues TTM $ 20 Millions Visit CELU's Income Statement
What are CELU's Sales? Visit CELU's Sales by Segment

Other Inventory Turnover Ratios
Celularity Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CELU's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CELU's Competitors
Inventory Turnover Ratio for CELU's Suppliers
Inventory Turnover Ratio for CELU's Customers

You may also want to know
CELU's Sales Growth Rates CELU's Pe Price to earnings ratio CELU's Receivables Turnover Ratio CELU's Stock Quote
CELU's Net Income Growth Rates CELU's Ps Price to Sales ratio CELU's Sales per Employee CELU's Asset Turnover Ratio
CELU's Net Margin CELU's Pb Price to Book ratio CELU's Financial Strength Ratios CELU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Healthcare Services Group Inc   93.98 $ 1,612.373  Millions$ 17  Millions
Meihua International Medical Technologies Co Ltd  74.44 $ 41.282  Millions$ 1  Millions
Newgenivf Group Limited  48.78 $ 3.771  Millions$ 0  Millions
Quest Diagnostics Inc  39.25 $ 7,370.000  Millions$ 188  Millions
Vaso Corporation  37.93 $ 34.424  Millions$ 1  Millions
Autolus Therapeutics Plc  34.23 $ 96.369  Millions$ 3  Millions
Adc Therapeutics Sa  32.85 $ 5.798  Millions$ 0  Millions
Harmony Biosciences Holdings inc   32.03 $ 198.000  Millions$ 6  Millions
Qhslab Inc   26.32 $ 0.881  Millions$ 0  Millions
Omada Health Inc   24.51 $ 88.247  Millions$ 4  Millions
Viemed Healthcare Inc   23.98 $ 114.822  Millions$ 5  Millions
Harvard Apparatus Regenerative Technology Inc   22.87 $ 0.646  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  22.84 $ 44.941  Millions$ 2  Millions
Lucid Diagnostics Inc   21.41 $ 9.784  Millions$ 0  Millions
Rosecliff Acquisition Corp I  21.00 $ 11.442  Millions$ 1  Millions
Teladoc Health Inc   20.01 $ 771.593  Millions$ 39  Millions
Agape Atp Corporation  19.56 $ 0.686  Millions$ 0  Millions
Labcorp Holdings Inc   19.37 $ 9,939.200  Millions$ 513  Millions
Aspira Women s Health inc   19.20 $ 5.142  Millions$ 0  Millions
Adapthealth Corp   18.22 $ 2,635.658  Millions$ 145  Millions
Hutchmed china Limited  18.01 $ 336.349  Millions$ 19  Millions
Neuronetics Inc   17.21 $ 76.000  Millions$ 4  Millions
Aurinia Pharmaceuticals Inc   16.31 $ 32.665  Millions$ 2  Millions
Nano X Imaging Ltd  14.93 $ 25.809  Millions$ 2  Millions
Precipio inc   14.80 $ 13.343  Millions$ 1  Millions
Rockwell Medical inc   13.74 $ 57.000  Millions$ 4  Millions
Natera Inc   13.62 $ 809.395  Millions$ 59  Millions
The Oncology Institute Inc   12.87 $ 205.502  Millions$ 16  Millions
Casi Pharmaceuticals inc   12.66 $ 10.636  Millions$ 1  Millions
Cryo cell International Inc   11.94 $ 7.377  Millions$ 1  Millions

Date modified: 2026-06-22T14:32:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.